Treace Medical Concepts

Treace Medical Concepts

TMCI· Manufacturing· Fiscal year ends in December

CEO pay in FY2025Stock -67.1% in FY2025

John T. Treace is the CEO of Treace Medical Concepts and was paid $5.4M in FY2025 (Dec), down 18%.

Pay$100 in the stock at the end of FY21 → $13
CEO pay is from each Treace Medical Concepts proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Executives5

See all
  1. 1John T. TreaceFY2025
  2. 2Mark L. HairFY2025
  3. 3Sean F. ScanlanFY2025
  4. 4Scot M. ElderFY2025
  5. 5Gaetano M. GuglielminoFY2025

Named executives and their total pay, from the Summary Compensation Table of the latest proxy.

Pay

See all

Treace Medical Concepts paid its 5 named executives $15.5M in total in FY2025 (Dec). CEO John T. Treace was paid $5.4M of that.

Name
John T. TreaceChief Executive Officer, Founder and Board Chair
Mark L. HairChief Financial Officer
Sean F. ScanlanChief Innovation Officer
Scot M. ElderChief Legal & Compliance Officer, Corporate Secretary
Gaetano M. GuglielminoChief Commercial OfficerNot disclosed

of each named executive, from the Summary Compensation Table of each proxy.

Peers

No disclosed peer group

No proxy on file names a pay peer group for Treace Medical Concepts. The peer group comes from the proxy statement, so it shows here when a proxy read has it.

Board5

See all
  • Richard W. MottDirector · 8 yr on the boardIndependentCompensation—Paid as an executive
  • John K. BakewellDirector · 3 yr on the boardIndependentAudit (Chair), Nominating, Compliance and ESG—Paid as an executive
  • Lawrence W. HamiltonDirector · 3 yr on the boardIndependentAudit, Compensation (Chair)—Paid as an executive
  • Jane E. KiernanDirector · 1 yr on the boardIndependentCompensation—Paid as an executive
  • Lance A. BerryDirector · 1 yr on the boardIndependentAudit—Paid as an executive

The board of the latest proxy (FY2023).

Activity

  1. Pay
    Treace Medical Concepts Chief Innovation Officer pay fell 25% to $2.3M. The stock fell 67% in FY2025 (Dec).
    DEF 14A
  2. Pay
    Treace Medical Concepts General counsel pay fell 53% to $2.1M. The stock fell 67% in FY2025 (Dec).
    DEF 14A
  3. Pay
    Treace Medical Concepts CFO pay rose 15% to $5.2M. The stock fell 67% in FY2025 (Dec).
    DEF 14A
  4. Pay
    Treace Medical Concepts CEO pay fell 18% to $5.4M. The stock fell 67% in FY2025 (Dec).
    DEF 14A
  5. Pay
    Treace Medical Concepts Division head pay fell 85% to $468.5K. The stock fell 67% in FY2025 (Dec).
    DEF 14A
  6. Pay
    Treace Medical Concepts Chief Innovation Officer pay rose 120% to $2.9M. The stock fell 45% in FY2023 (Dec).
    DEF 14A
  7. Pay
    Treace Medical Concepts General counsel pay rose 44% to $4.6M. The stock fell 42% in FY2024 (Dec).
    DEF 14A
  8. Pay
    Treace Medical Concepts General counsel pay rose 139% to $3.2M. The stock fell 45% in FY2023 (Dec).
    DEF 14A
  9. Pay
    Treace Medical Concepts CEO pay fell 22% to $6.6M. The stock fell 42% in FY2024 (Dec).
    DEF 14A
  10. Pay
    Treace Medical Concepts CFO pay rose 205% to $4.7M. The stock fell 45% in FY2023 (Dec).
    DEF 14A
  11. Pay
    Treace Medical Concepts CEO pay rose 133% to $8.4M. The stock fell 45% in FY2023 (Dec).
    DEF 14A
  12. Pay
    Treace Medical Concepts Division head pay rose 128% to $3.3M. The stock fell 45% in FY2023 (Dec).
    DEF 14A

Filings6

See all
Proxy statementDEF 14AApr 6, 2026FY2025
Annual report10-KFeb 27, 2026FY2025
Proxy statementDEF 14AApr 7, 2025FY2024
Annual report10-KFeb 27, 2025FY2024
Proxy statementDEF 14AApr 2, 2024FY2023
Annual report10-KFeb 27, 2024FY2023
For the press:Download CSVDownload PNGHow to use our data